EP 1409715 A4 20040421 - METHODS AND MATERIALS RELATING TO NEUROTRIMIN-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES
Title (en)
METHODS AND MATERIALS RELATING TO NEUROTRIMIN-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES
Title (de)
VERFAHREN UND MATERIALIEN VERWANDT MIT NEUROTRIMINAEHNLICHEN POLYPEPTIDEN UND POLYNUKLEOTIDEN
Title (fr)
PROCEDES ET MATERIAUX CONCERNANT DES POLYPEPTIDES ET DES POLYNUCLEOTIDES DU TYPE NEUROTRIMIN
Publication
Application
Priority
- US 0103651 W 20010202
- US 49691400 A 20000203
- US 56087500 A 20000427
- US 63208500 A 20000802
Abstract (en)
[origin: WO0157175A2] The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted neurotrimin-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human thalamus (Hyseq clone identification number 10468562). Other aspects of the invention include vectors containing processes for producing novel human secreted neurotrimin-like polypeptides, and antibodies specific for such polypeptides.
IPC 1-7
IPC 8 full level
G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61P 1/04 (2006.01); A61P 9/10 (2006.01); A61P 13/12 (2006.01); A61P 19/02 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 35/02 (2006.01); A61P 37/06 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 16/40 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/16 (2006.01); C12N 9/50 (2006.01); C12N 9/64 (2006.01); C12N 15/09 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 9/10 (2017.12); A61P 13/12 (2017.12); A61P 19/02 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/22 (2017.12); A61P 25/24 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 33/00 (2017.12); A61P 35/02 (2017.12); A61P 37/06 (2017.12); C07K 14/47 (2013.01); C12N 9/16 (2013.01); C12N 9/6432 (2013.01); C12Y 304/21006 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
- [E] WO 0175067 A2 20011011 - HYSEQ INC [US], et al
- [E] WO 0186003 A
- [XD] DATABASE EMBL [online] 29 March 1999 (1999-03-29), "Human DNA sequence from clone RP3-402N21 on chromosome 6p21.1-21.31", XP002236303, retrieved from EBI Database accession no. AL049553
- [X] DATABASE EMBL [online] 3 August 1999 (1999-08-03), XP002236304, retrieved from EBI Database accession no. AI935159
- [A] GIL O.D. ET AL: "Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions", THE JOURNAL OF NEUROSCIENCE, vol. 18, no. 22, 1998, pages 9312 - 9325, XP002236302
- See references of WO 0157175A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0157175 A2 20010809; WO 0157175 A3 20040226; AU 3665801 A 20010814; CA 2399644 A1 20010809; EP 1409715 A2 20040421; EP 1409715 A4 20040421; JP 2004500082 A 20040108
DOCDB simple family (application)
US 0103651 W 20010202; AU 3665801 A 20010202; CA 2399644 A 20010202; EP 01908832 A 20010202; JP 2001557993 A 20010202